Macleods Pharmaceuticals is recalling 32 lots of losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets. The recall was prompted after a potentially carcinogenic impurity, ...
This study demonstrates that candesartan had greater efficacy in lowering arterial pressure when compared to losartan. Moreover, the duration of effect and response/control rates were significantly ...
Novel oral suspension addresses critical patient safety needs for hypertension treatment for patients unable to swallow tablets U.S. losartan market totals $256M annually with 71M prescriptions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback